483
AbbVie Inc.AbbVie Inc. – FDA 483, Jun 18, 2024
Record Details
AbbVie Inc. in North Chicago, IL, a sterile drug manufacturer, was cited for deficiencies in laboratory controls. The inspection revealed that the firm lacked scientifically sound justification for its Survanta stability testing program and failed to protect microbiology plates from desiccation during incubation. These issues indicate a failure to ensure the quality and purity of drug products and in-process materials.
View Company Profile
ID · 7e512946-7c93-4d23-9562-94c9c7dc0048
Other documents for AbbVie Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.